Natco

NATCO pharma is a Hyderabad-based pharmaceutical company which became famous when the Indian Patent office used the WTO-TRIPS 2006 agreement to give it permission to replicate and produce a generic version of Bayer’s cancer drug Nexavar which would bring down the price of the drug by 97%. This was the first instance of a country giving a compulsory licence and led to protracted legal stand-off which finally ended in NATCO’s favour.

Videos

Health Calculator